Results 291 to 300 of about 1,463,832 (396)

Transforming Growth Factor‐Beta Signaling in Cancer: Therapeutic Implications, Challenges, and Pathways to Progress

open access: yesMedComm – Oncology, Volume 4, Issue 3, September 2025.
TGF‐β inhibition is emerging as a promising cancer therapy, yet translating laboratory success to bedside implementation has suffered significant setbacks. The associated challenges include adverse drug reactions, inadequate predictive models, and activation of alternative signaling pathways.
Faizah A. Alabi   +5 more
wiley   +1 more source

1048 Parotid gland sparing using inverse planning for radiotherapy of nasopharyngeal carcinomas

open access: bronze, 1997
Kenneth Forster   +13 more
openalex   +1 more source

Dosimetric and robustness evaluation of biaxially rotational dynamic radiation therapy with robust optimization

open access: yesJournal of Applied Clinical Medical Physics, Volume 26, Issue 8, August 2025.
Abstract Background Studies suggest that integrating robust planning and noncoplanar volumetric modulated arc therapy (VMAT) may be a useful strategy for maximizing the benefits of dose delivery while maintaining resilience to uncertainty; however, the robustness of target coverage and the dose‐sparing performance for organs at risk of techniques that ...
Kouta Hirotaki   +6 more
wiley   +1 more source

Capecitabine Maintenance Therapy in Patients with Residual Nasopharyngeal Carcinoma: A Single-Arm, Phase II Trial. [PDF]

open access: yesClin Cancer Res
Cao X   +13 more
europepmc   +1 more source

C‐Reactive Protein to Lymphocyte Ratio (CLR) and Lactate Dehydrogenase to Albumin Ratio (LAR) as Prognostic Biomarkers in Acral Melanoma: Association With Tertiary Lymphoid Structures and Immune Cell Infiltration

open access: yesCancer Medicine, Volume 14, Issue 15, August 2025.
ABSTRACT Objective To investigate the correlation between peripheral blood CRP‐to‐lymphocyte ratio (CLR) and lactate dehydrogenase‐to‐albumin ratio (LAR) levels, prognosis, and the tumor microenvironment (TME) in patients with acral melanoma (AM), with a focus on tertiary lymphoid structures (TLS) and immune cell infiltration.
Donglin Kang   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy